Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

NCT01233895

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Sanofi-Aventis Investigational Site Number 250002 Lille, France

Sanofi-Aventis Investigational Site Number 250001 Nantes, France

Sanofi-Aventis Investigational Site Number 250003 Vandœuvre-lès-Nancy, France

Sanofi-Aventis Investigational Site Number 380001 Torino, Italy

View Trial Details

Completed

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

NCT00095680

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

NCT00689000

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +21 more
Locations: Nexus Oncology Ltd Edinburgh, Scotland, United Kingdom

View Trial Details

Completed

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

NCT00087867

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction

NCT00713505

Conditions: Burkitt Lymphoma, Cancer Survivor, Cognitive/Functional Effects, +28 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Allo BMT in Advanced Leukemia or High Grade Lymphoma

NCT00186290

Conditions: Blood and Marrow Transplant (BMT), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

NCT00277160

Conditions: Adnexal Diseases, Agranulocytosis, Breast Cancer, +39 more
Locations: Not specified

View Trial Details

Completed

Assess the Oral Bioavailability of New ABT-263 Formulations

NCT00743028

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: Site Reference ID/Investigator# 10281 Encinitas, California, United States

Site Reference ID/Investigator# 10282 Santa Monica, California, United States

Site Reference ID/Investigator# 16341 Bethesda, Maryland, United States

Site Reference ID/Investigator# 9441 Lebanon, New Hampshire, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

NCT00002522

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Fox Chase - Temple Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

NCT00002510

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations: Temple University Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions